818 filings
8-K
LSTA
Lisata Therapeutics Inc
18 Nov 19
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019
6:21am
8-K
LSTA
Lisata Therapeutics Inc
6 Nov 19
Caladrius Biosciences Reports 2019 Third Quarter and Nine Month Financial Results and Provides Corporate Update
4:10pm
10-Q
2019 Q3
LSTA
Lisata Therapeutics Inc
Quarterly report
6 Nov 19
4:02pm
8-K
LSTA
Lisata Therapeutics Inc
8 Aug 19
Caladrius Biosciences Reports 2019 Second Quarter and First Six Months Financial Results and Provides Corporate Update
4:08pm
10-Q
2019 Q2
LSTA
Lisata Therapeutics Inc
Quarterly report
8 Aug 19
4:03pm
8-K
bblnslw1db8s952wg
27 Jun 19
Submission of Matters to a Vote of Security Holders
11:02am
8-K
p4alb4tgf5cg0r
9 May 19
Caladrius Biosciences, Inc. Reports 2019 First Quarter Financial Results and Provides Corporate Update
4:07pm
8-K/A
yslfegv
11 Apr 19
Regulation FD Disclosure
3:09pm
8-K
fff7dyak0j
11 Apr 19
Regulation FD Disclosure
12:31pm
424B5
poae689ndfh cfoaj
20 Mar 19
Prospectus supplement for primary offering
5:19pm
424B5
p8f2hj
14 Mar 19
Prospectus supplement for primary offering
4:23pm
8-K
ifuuvh5ztk oq9kxh08
14 Mar 19
Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results
4:18pm
8-K
x5tnwf
13 Feb 19
Other Events
5:24pm
8-K
6gozsz9dngk
22 Jan 19
Regulation FD Disclosure
8:00am
4
rs553
16 Jan 19
CALADRIUS BIOSCIENCES / Joseph Talamo ownership change
4:22pm
4
cn14u1mxfjn9jgw71
16 Jan 19
CALADRIUS BIOSCIENCES / David J Mazzo ownership change
4:19pm